Citations

Clear

107 citation(s) found for "Shi, Min".

Feeling run down: exercise‐induced pancytopenia
Huffman, Brandon M. , Wiisanen, Jeff, Shi, Min , Go, Ronald S.

Mayo Clinic

British Journal of Haematology | April 17, 2017 | Volume: 177 | Issue: 5 | Pages: 672-672

10.1111/bjh.14648 | PMID 28419423 Get It

Clinical course of patients with incidental finding of 20q‐ in the bone marrow without a morphologic evidence of myeloid neoplasm
Jawad, Majd, Oliveira, Jennifer L. , Hoyer, James D., Hook, C. Christopher , Herrick, Jennifer L. , Jawad, Majd D, Shi, Min , Go, Ronald S.

Mayo Clinic

American Journal of Hematology | March 1, 2016 | Volume: 91 | Issue: 6 | Pages: 556-559

10.1002/ajh.24347 | PMID 26928533 Get It

Deletion of the long arm of chromosome 20 (20q‐) is a frequent finding in bone marrow karyotypes, mainly associated with myeloid neoplasms (MNs). Its clinical significance in the setting of normal bone marrow morphology is unclear. We described the clinical characteristics, cytogenetic findings, and outcome of 102 such patients seen at our institution from 2000‐2014. Their median age was 66 years. The indication for bone marrow biopsy was either unexplained cytopenias (48%) or hematologic cancer staging/reevaluation (52%). In 88 (86%) patients, 20q‐ was an isolated finding. Thirty‐nine (38%) patients previously received chemotherapy and 88 (86%) had cytopenias at the time of 20q‐ finding. After a median of 35 months, 12 (13%) patients developed MNs: 10 myelodysplastic syndromes, one acute myeloid leukemia and one myeloproliferative neoplasm. None of 14 patients with normal blood counts, but 7 of 35 (20%) with mild cytopenias, and 5 of 53 (9%) with moderate/severe cytopenias developed MNs. We did not find an association between the number of metaphases with 20q‐ and the development of MN. The incidental finding of 20q‐ in the bone marrow generally does not portend an early stage MN. Particularly, those without cytopenias at the time of diagnosis may have a good prognosis. Am. J. Hematol. 91:556–559, 2016. © 2016 Wiley Periodicals, Inc.
Plasma cell myeloma with numerous cytoplasmic granules
Shi, Min , He, Rong , Shi, Min

Mayo Clinic

Blood | February 25, 2016 | Volume: 127 | Issue: 8 | Pages: 1073-1073

10.1182/blood-2015-12-685214 | PMID 27351034 Get It

Spur cell anemia in the setting of progressive liver allograft failure
Partain, Daniel K. , Poterucha, John J., Ashrani, Aneel A. , Thompson, Carrie A. , Botero, Juliana Perez , Shi, Min , Partain, Daniel K

Mayo Clinic

American Journal of Hematology | February 14, 2016 | Volume: 91 | Issue: 10 | Pages: 1061-1061

10.1002/ajh.24331 | PMID 26874796 Get It

Transient monosomy 7 in a chronic myelogenous leukemia patient during nilotinib therapy: a case report
Jawad, Majd, Begna, Kebede H. , Reichard, Kaaren K. , Jawad, Majd D, Go, Ronald S. , Ketterling, Rhett P. , Shi, Min

Mayo Clinic

Clinical Case Reports | February 8, 2016 | Volume: 4 | Issue: 3 | Pages: 282-286

10.1002/ccr3.506 | PMID 27014453 Get It

Key Clinical MessageTyrosine kinase inhibitor treated chronic myelogenous leukemia patients with monosomy 7 arising in Philadelphia chromosome negative (Ph−) cells tend to evolve into MDS/AML. However, monosomy 7 in Ph− cells can be a transient finding, and it is not an absolute indication of the emergence of a new myeloid malignancy.
Decreased normal NK-cells is a characteristic of T-cell large granular lymphocytic leukemia and is strongly associated with cytopenia
Neff, Jadee , Jevremović, Dragan , Morice, William G. , Neff, Jadee L, Shi, Min , Morice, William George , Jevremovic, Dragan

Mayo Clinic

Leukemia & Lymphoma | December 21, 2015 | Volume: 57 | Issue: 5 | Pages: 1230-1233

10.3109/10428194.2015.1081191 | PMID 26689813 Get It

A case of lymphoproliferative disorder of NK‐cells: aggressive immunophenotype but indolent behavior
Savage, Natasha M. , Salman, Huda , Morice, William G. , Shi, Min , Morice, William George , Salman, Huda

Mayo Clinic

Clinical Case Reports | August 11, 2015 | Volume: 3 | Issue: 9 | Pages: 740-743

10.1002/ccr3.333 | PMID 26401278 Get It

Key Clinical MessageDistinguishing chronic lymphoproliferative disorder of NK‐cells from aggressive NK‐cell leukemia is critical because they have distinct clinical course and management. Immunophenotyping plays a key role in distinguishing these two entities, however, it could not be used as sole criteria and clinical/laboratory findings are equally important.